NSTL国家科技图书文献中心

1. SKP1-CUL1-F-box: Key molecular targets affecting disease progression NSTL国家科技图书文献中心

Zeng, Xiangrong | Cao, Jiaying ... - 《The FASEB Journal》 - 2025,39(2) - e70326～e70326 - 共24页

摘要： cell cycle progression, DNA replication, oxidative | , progression, and prognosis of malignant tumors. By | functions in cellular physiology and disease* pathogenesis.* | The correct synthesis and degradation of | proteins are vital for numerous biological processes in

关键词： CUL1 | disease progression | F‐box | molecular target | SKP1 | F-box

2. Urinary Sodium Excretion and Kidney Disease Progression in IgA Nephropathy: A Cohort Study NSTL国家科技图书文献中心

Yu, Guizhen | Wang, Xuliang ... - 《American Journal of Nephrology》 - 2025,56(1) - 85～93 - 共9页

摘要： excretion and kidney disease* progression events, defined* | nephropathy reached composite kidney disease progression | events. The risk of kidney disease* progression events* | associated with kidney disease* progression events in IgA* | intake in the risk of chronic kidney disease

关键词： IgA nephropathy | Urinary sodium excretion | Kidney disease progression

3. Risk Factors for Disease Progression in Thermal Ablation of Papillary Thyroid Cancer—A Large-sample Analysis NSTL国家科技图书文献中心

Yu-Lin Fei | Ying Wei ... - 《Academic radiology》 - 2025,32(6) - 3269～3280 - 共12页

摘要： analyze risk factors influencing disease* progression in* | important factors for disease* progression. Cox univariable* | disease progression. Variables achieving statistical | 25 months. Disease progression-free survival rates | %, respectively. Independent predictors of disease progression

关键词： Ablation Techniques; Disease progression-free survival; Papillary thyroid carcinoma

4. Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review NSTL国家科技图书文献中心

Muni-Lofra, R. | Coratti, G.... - 《Neuromuscular disorders》 - 2025,49 - 105341～105341 - 共13页

摘要： fatigue or pain. When assessing disease progression | development to mild impairment. Assessing disease* severity* | individuals or populations against general norms, or disease | -specific measures designed to fit disease* characteristics* | of disease* modifying therapies and the need to*

关键词： Spinal muscular atrophy | Outcome measures | Disease modifying therapies | Disease progression

5. Mixture Disease Progression Model to Predict and Cluster the Long-Term Trajectory of Cognitive Decline in Alzheimer's Disease NSTL国家科技图书文献中心

Hanazawa, Ryoichi | Sato, Hiroyuki ... - 《Therapeutic innovation & regulatory science.》 - 2025,59(2) - 264～277 - 共14页

摘要： heterogeneity of disease* progression among the patients* | disease progression model to predict and cluster the | varying disease* progression speeds among the patients* | BackgroundAlzheimer's disease* (AD) is a* | neurodegenerative disease* for which many clinical trials failed to*

关键词： Alzheimer's disease | Cognitive assessment | Disease progression model | Mixture model | Nonlinear mixed-effects model

6. Impact of Catheter Ablation of Atrial Fibrillation on Disease Progression NSTL国家科技图书文献中心

Benali, Karim | Macle, Laurent ... - 《JACC..Clinical electrophysiology.》 - 2025,11(2) - 421～435 - 共15页

摘要： capable of delaying or halting disease progression | processes responsible for disease* progression. Catheter* | disease progression was mostly speculative. However | critical to optimally affect the disease* progression. The* | care costs. The progression* from paroxysmal (defined*

关键词： ablation | antiarrhythmic drugs | atrial fibrillation | cryoablation | paroxysmal | persistent | pulmonary vein isolation | radiofrequency ablation

7. Impact of COVID-19 on Disease Progression and Postoperative Complications in Patients with Head and Neck Cancer NSTL国家科技图书文献中心

Nadarajan, Abinaya R... | George, Nebu Abraham ... - 《Indian journal of surgical oncology》 - 2025,16(2) - 491～495 - 共5页

摘要： study is to assess the disease* progression due to* | %). Early disease* was noted in 49 patients (30.8%) and* | locally advanced disease* in 108 patients (67.9%). Mean* | duration of delay in surgery was 4 weeks. Disease | progression was noted in 27 patients (17%) out of which 15

关键词： Head and neck cancer | COVID-19 | Delay | Disease progression

8. Symptom clusters, fear of disease progression, and quality of life in postoperative gastric cancer patients: a cross-sectional study NSTL国家科技图书文献中心

Deng, Huili | Yang, Tiantian ... - 《Supportive care in cancer》 - 2025,33(3) - Article: 219～Article: 219 - 共13页

摘要：, fear of disease* progression, and quality of life (QoL* | symptom clusters, fear of disease* progression, and* | , fear of disease* progression, and quality of life of* | among symptom clusters, fear of disease progression | fear of disease* progression (r = 0.260, P < 0.01*

关键词： Gastric cancer | Symptom clusters | Fear of disease progression | Quality of life | Surgery

9. Cerebrospinal fluid tau and disease progression in early Parkinson's disease: an 8-year longitudinal study NSTL国家科技图书文献中心

Xu, Fang | Huang, Hongyan ... - 《Journal of neurology》 - 2025,272(1) - Article: 61～Article: 61 - 共10页

摘要： associated with disease* progression in early PD patients* | matched controls from the Parkinson's Progression | Parkinson's Disease* Rating Scale (MDS-UPDRS) III (estimate* | Objective To explore whether CSF | phosphorylated tau-181 (P-tau181) and total tau (T-tau) are

关键词： Parkinson's disease | Tau | Motor progression | alpha-synuclein | Dopamine transporter imaging

10. Profiles of disease progression and predictors of mortality in Colombian patients with amyotrophic lateral sclerosis: a comprehensive longitudinal study NSTL国家科技图书文献中心

Ortiz-Corredor, Fern... | Correa-Arrieta, Cris...... - 《Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration》 - 2025,26(1/2) - 141～148 - 共8页

摘要： mortality and characterizing disease* progression patterns* | Coast criteria. Disease* progression was assessed using* | (GMM) to explore ALS progression* trajectories* | progression trajectories: slow, intermediate, and rapid | . This study highlights the heterogeneity in disease

摘要： cell cycle progression, DNA replication, oxidative | , progression, and prognosis of malignant tumors. By | functions in cellular physiology and disease* pathogenesis.* | The correct synthesis and degradation of | proteins are vital for numerous biological processes in

关键词： CUL1 | disease progression | F‐box | molecular target | SKP1 | F-box

摘要： excretion and kidney disease* progression events, defined* | nephropathy reached composite kidney disease progression | events. The risk of kidney disease* progression events* | associated with kidney disease* progression events in IgA* | intake in the risk of chronic kidney disease

关键词： IgA nephropathy | Urinary sodium excretion | Kidney disease progression

关键词： Ablation Techniques; Disease progression-free survival; Papillary thyroid carcinoma

关键词： Spinal muscular atrophy | Outcome measures | Disease modifying therapies | Disease progression

摘要： heterogeneity of disease* progression among the patients* | disease progression model to predict and cluster the | varying disease* progression speeds among the patients* | BackgroundAlzheimer's disease* (AD) is a* | neurodegenerative disease* for which many clinical trials failed to*

关键词： Alzheimer's disease | Cognitive assessment | Disease progression model | Mixture model | Nonlinear mixed-effects model

摘要： capable of delaying or halting disease progression | processes responsible for disease* progression. Catheter* | disease progression was mostly speculative. However | critical to optimally affect the disease* progression. The* | care costs. The progression* from paroxysmal (defined*

关键词： ablation | antiarrhythmic drugs | atrial fibrillation | cryoablation | paroxysmal | persistent | pulmonary vein isolation | radiofrequency ablation

摘要： study is to assess the disease* progression due to* | %). Early disease* was noted in 49 patients (30.8%) and* | locally advanced disease* in 108 patients (67.9%). Mean* | duration of delay in surgery was 4 weeks. Disease | progression was noted in 27 patients (17%) out of which 15

关键词： Head and neck cancer | COVID-19 | Delay | Disease progression

摘要：, fear of disease* progression, and quality of life (QoL* | symptom clusters, fear of disease* progression, and* | , fear of disease* progression, and quality of life of* | among symptom clusters, fear of disease progression | fear of disease* progression (r = 0.260, P < 0.01*

关键词： Gastric cancer | Symptom clusters | Fear of disease progression | Quality of life | Surgery

摘要： associated with disease* progression in early PD patients* | matched controls from the Parkinson's Progression | Parkinson's Disease* Rating Scale (MDS-UPDRS) III (estimate* | Objective To explore whether CSF | phosphorylated tau-181 (P-tau181) and total tau (T-tau) are

关键词： Parkinson's disease | Tau | Motor progression | alpha-synuclein | Dopamine transporter imaging

摘要： mortality and characterizing disease* progression patterns* | Coast criteria. Disease* progression was assessed using* | (GMM) to explore ALS progression* trajectories* | progression trajectories: slow, intermediate, and rapid | . This study highlights the heterogeneity in disease

关键词： Amyotrophic lateral sclerosis | disease progression | survival rate | Colombia | ALSFRS-R | prognosis

4008-161-200 800-990-8900

国家科技图书文献中心

摘要： cell cycle progression, DNA replication, oxidative | , progression, and prognosis of malignant tumors. By | functions in cellular physiology and disease pathogenesis. | The correct synthesis and degradation of | proteins are vital for numerous biological processes in

关键词： CUL1 | disease progression | F‐box | molecular target | SKP1 | F-box

摘要： excretion and kidney disease progression events, defined | nephropathy reached composite kidney disease progression | events. The risk of kidney disease progression events | associated with kidney disease progression events in IgA | intake in the risk of chronic kidney disease

关键词： IgA nephropathy | Urinary sodium excretion | Kidney disease progression

摘要： analyze risk factors influencing disease progression in | important factors for disease progression. Cox univariable | disease progression. Variables achieving statistical | 25 months. Disease progression-free survival rates | %, respectively. Independent predictors of disease progression

关键词： Ablation Techniques; Disease progression-free survival; Papillary thyroid carcinoma

摘要： fatigue or pain. When assessing disease progression | development to mild impairment. Assessing disease severity | individuals or populations against general norms, or disease | -specific measures designed to fit disease characteristics | of disease modifying therapies and the need to

关键词： Spinal muscular atrophy | Outcome measures | Disease modifying therapies | Disease progression

摘要： heterogeneity of disease progression among the patients | disease progression model to predict and cluster the | varying disease progression speeds among the patients | BackgroundAlzheimer's disease (AD) is a | neurodegenerative disease for which many clinical trials failed to

关键词： Alzheimer's disease | Cognitive assessment | Disease progression model | Mixture model | Nonlinear mixed-effects model

摘要： capable of delaying or halting disease progression | processes responsible for disease progression. Catheter | disease progression was mostly speculative. However | critical to optimally affect the disease progression. The | care costs. The progression from paroxysmal (defined

关键词： ablation | antiarrhythmic drugs | atrial fibrillation | cryoablation | paroxysmal | persistent | pulmonary vein isolation | radiofrequency ablation

摘要： study is to assess the disease progression due to | %). Early disease was noted in 49 patients (30.8%) and | locally advanced disease in 108 patients (67.9%). Mean | duration of delay in surgery was 4 weeks. Disease | progression was noted in 27 patients (17%) out of which 15

关键词： Head and neck cancer | COVID-19 | Delay | Disease progression

摘要：, fear of disease progression, and quality of life (QoL | symptom clusters, fear of disease progression, and | , fear of disease progression, and quality of life of | among symptom clusters, fear of disease progression | fear of disease progression (r = 0.260, P < 0.01

关键词： Gastric cancer | Symptom clusters | Fear of disease progression | Quality of life | Surgery

摘要： associated with disease progression in early PD patients | matched controls from the Parkinson's Progression | Parkinson's Disease Rating Scale (MDS-UPDRS) III (estimate | Objective To explore whether CSF | phosphorylated tau-181 (P-tau181) and total tau (T-tau) are

关键词： Parkinson's disease | Tau | Motor progression | alpha-synuclein | Dopamine transporter imaging

摘要： mortality and characterizing disease progression patterns | Coast criteria. Disease progression was assessed using | (GMM) to explore ALS progression trajectories | progression trajectories: slow, intermediate, and rapid | . This study highlights the heterogeneity in disease

关键词： Amyotrophic lateral sclerosis | disease progression | survival rate | Colombia | ALSFRS-R | prognosis

4008-161-200 800-990-8900

国家科技图书文献中心

摘要： cell cycle progression, DNA replication, oxidative | , progression, and prognosis of malignant tumors. By | functions in cellular physiology and disease* pathogenesis.* | The correct synthesis and degradation of | proteins are vital for numerous biological processes in

摘要： excretion and kidney disease* progression events, defined* | nephropathy reached composite kidney disease progression | events. The risk of kidney disease* progression events* | associated with kidney disease* progression events in IgA* | intake in the risk of chronic kidney disease

摘要： heterogeneity of disease* progression among the patients* | disease progression model to predict and cluster the | varying disease* progression speeds among the patients* | BackgroundAlzheimer's disease* (AD) is a* | neurodegenerative disease* for which many clinical trials failed to*

摘要： capable of delaying or halting disease progression | processes responsible for disease* progression. Catheter* | disease progression was mostly speculative. However | critical to optimally affect the disease* progression. The* | care costs. The progression* from paroxysmal (defined*

摘要： study is to assess the disease* progression due to* | %). Early disease* was noted in 49 patients (30.8%) and* | locally advanced disease* in 108 patients (67.9%). Mean* | duration of delay in surgery was 4 weeks. Disease | progression was noted in 27 patients (17%) out of which 15

摘要：, fear of disease* progression, and quality of life (QoL* | symptom clusters, fear of disease* progression, and* | , fear of disease* progression, and quality of life of* | among symptom clusters, fear of disease progression | fear of disease* progression (r = 0.260, P < 0.01*

摘要： associated with disease* progression in early PD patients* | matched controls from the Parkinson's Progression | Parkinson's Disease* Rating Scale (MDS-UPDRS) III (estimate* | Objective To explore whether CSF | phosphorylated tau-181 (P-tau181) and total tau (T-tau) are

摘要： mortality and characterizing disease* progression patterns* | Coast criteria. Disease* progression was assessed using* | (GMM) to explore ALS progression* trajectories* | progression trajectories: slow, intermediate, and rapid | . This study highlights the heterogeneity in disease